Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)
- 4 May 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 41 (6), 1345-1348
- https://doi.org/10.1007/s10072-020-04448-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Miller Fisher syndrome and polyneuritis cranialis in COVID-19Neurology, 2020
- Guillain–Barré Syndrome Associated with SARS-CoV-2The New England Journal of Medicine, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?The Lancet Neurology, 2020
- Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologistsStroke and Vascular Neurology, 2020
- Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective studyBMJ, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Neurological Complications during Treatment of Middle East Respiratory SyndromeJournal of Clinical Neurology, 2017